Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards $17.9M to SRA International for Continued Informatics Support for TCGA Project

Premium

Last week, SRA international announced that it had received a task order from the National Institutes of Health, worth about $17.9 million over five years if all options are exercised, to provide continued bioinformatics support for The Cancer Genome Atlas Project.

The first 18 months of the task order will be funded under the American Reinvestment and Recovery Act.

Further details of the contract were not disclosed.

SRA will use the funds to develop an algorithm repository as well as provide direct bioinformatics support to the TCGA Program Office, in addition to providing continued support for the data coordinating center and the TCGA data portal.

Since TCGA's inception in 2006, SRA has been responsible for collecting, transforming, disseminating, and conducting quality assurance on the research data generated by the more than 60 organizations participating in the project, which include laboratories, cancer centers, universities, and private companies.

The group has also been involved in developing and supporting software for data submission and quality control as well as an online data-sharing portal for the project.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.